Review of the Estonian pharmaceutical sector: towards the development of a national medicines policy
dc.contributor.author | Kanavos P | |
dc.contributor.author | Vandoros S | |
dc.contributor.author | Habicht J | |
dc.contributor.author | de Joncheere K | |
dc.contributor.other | WHO Regional Office for Europe | |
dc.date.accessioned | 2010-01-11T10:35:25Z | |
dc.date.accessioned | 2022-10-03T11:42:09Z | |
dc.date.available | 2010-01-11T10:35:25Z | |
dc.date.available | 2022-10-03T11:42:09Z | |
dc.date.issued | 2009 | |
dc.identifier.uri | http://hdl.handle.net/10062/85140 | |
dc.subject | ravimid | |
dc.subject | ravimipoliitika | |
dc.subject | finantseerimine | |
dc.subject | võrdsus | |
dc.subject | ebavõrdsus | |
dc.subject | tervishoiukorraldus | |
dc.subject | kulud | |
dc.subject | patsiendid | |
dc.subject | apteegid | |
dc.subject | ravikindlustus | |
dc.subject | haiglad | |
dc.subject | haiglaravi | |
dc.subject | ravi | |
dc.title | Review of the Estonian pharmaceutical sector: towards the development of a national medicines policy | |
dc.type | Raport |